Frazer I H, Fernando G J, Fowler N, Leggatt G R, Lambert P F, Liem A, Malcolm K, Tindle R W
Center for Immunology and Cancer Research, University of Queensland, Department of Medicine, Princess Alexandra Hospital, Woolloongabba, Australia.
Eur J Immunol. 1998 Sep;28(9):2791-800. doi: 10.1002/(SICI)1521-4141(199809)28:09<2791::AID-IMMU2791>3.0.CO;2-B.
When expressed as a transgene from the keratin 14 (K14) promoter in an MHC class II-deficient mouse, I-Ab expressed in thymic cortical epithelium promotes positive but not negative selection of I-Ab-restricted CD4+ T cells (Laufer, T. M. et al., Nature 1996. 383:81-85). Transgenic mice expressing the E7 protein of human papilloma virus 16 from the K14 promoter were studied to determine the consequence of expression of a cytoplasmic/ nuclear protein from the K14 promoter. K14E7-transgenic mice express E7 in the thymus and skin without evidence for autoimmunity to E7. Repeated immunization of FVB(H-2q) or F1(C57BL/6JxFVB) mice with E7 elicited similar antibody responses to the defined B cell epitopes of E7 in K14E7-transgenic and non-transgenic animals. In contrast, for each genetic background, a single immunization with E7 elicited demonstrable T cell proliferative responses to the major promiscuous T helper epitope of E7 in the transgenic but not the non-transgenic animals. Further, E7-immunized non-transgenic F1 (FVBxC57BL/6J) animals developed strong E7-specific cytotoxic T lymphocyte (CTL) responses and were protected against challenge with E7+ tumors, whereas similarly immunized K14E7-transgenic animals had a markedly reduced CTL response to E7 and no E7-specific tumor protection was observed, although the antibody and CTL response to ovalbumin was normal. Expression of E7 protein as a transgene from the K14 promoter in the skin and thymus thus induces E7-specific tolerance in the cytotoxic T effector repertoire, together with expansion of the E7-specific T helper repertoire. These findings demonstrate that limited tissue distribution of an autoantigen may result in "split" tolerance to that autoantigen.
当在MHC II类缺陷小鼠中从角蛋白14(K14)启动子作为转基因表达时,在胸腺皮质上皮中表达的I-Ab促进I-Ab限制性CD4 + T细胞的阳性选择而非阴性选择(Laufer,T.M.等人,《自然》,1996年。383:81 - 85)。研究了从K14启动子表达人乳头瘤病毒16的E7蛋白的转基因小鼠,以确定从K14启动子表达细胞质/核蛋白的后果。K14E7转基因小鼠在胸腺和皮肤中表达E7,没有针对E7的自身免疫证据。用E7对FVB(H-2q)或F1(C57BL/6JxFVB)小鼠进行重复免疫,在K14E7转基因和非转基因动物中引发了对E7定义的B细胞表位的相似抗体反应。相反,对于每种遗传背景,用E7进行单次免疫在转基因动物而非非转基因动物中引发了对E7主要混杂T辅助表位的可证明的T细胞增殖反应。此外,用E7免疫的非转基因F1(FVBxC57BL/6J)动物产生了强烈的E7特异性细胞毒性T淋巴细胞(CTL)反应,并受到针对E7 +肿瘤攻击的保护,而同样免疫的K14E7转基因动物对E7的CTL反应明显降低,未观察到E7特异性肿瘤保护,尽管对卵清蛋白的抗体和CTL反应正常。因此,从K14启动子作为转基因在皮肤和胸腺中表达E7蛋白会在细胞毒性T效应细胞库中诱导E7特异性耐受性,同时扩大E7特异性T辅助细胞库。这些发现表明自身抗原的有限组织分布可能导致对该自身抗原的“分裂”耐受性。